SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is trending as investors aggressively debate the company's future ahead of a confirmed 1-for-12 reverse stock split, with the community divided between those holding for a potential recovery and those bracing for further downside. While some traders are focused on unusual call option activity and potential short squeeze setups, many are expressing frustration with management and ongoing concerns regarding the company's long-term viability in the competitive streaming sector.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is seeing intense trading activity driven by unconfirmed market rumors of a potential M&A event, leading investors to actively debate the company's valuation against its rare-disease franchise. The community is focused on the possibility of a buyout premium, with many long-term shareholders closely monitoring the unusual volume and pre-market price action for signs of an institutional entry or formal confirmation.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as investors debate its potential for rapid growth versus risks of it being a highly speculative pump-and-dump scheme. While some in the community are aggressively promoting it as an early-stage opportunity with low market cap upside, others warn of significant manipulation and advise caution regarding its long-term viability.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

The 4Chan crypto community is actively rallying around the token's identity as a 'cultural index' and the 'Bitcoin of memecoins,' emphasizing its organic growth and long-term potential for generational wealth. Discussions center on its unique tokenomics, including blacklisted wallets and high liquidity, as supporters view current market volatility as a prime accumulation opportunity for the next major leg up.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund (VCX) is trending due to massive volatility on its first day of trading, with investors debating the disconnect between its soaring market price and the underlying net asset value. Community discussions are split between excitement over gaining retail access to high-profile private AI and tech holdings like Anthropic and SpaceX, and warnings from those viewing the current valuation as an unsustainable pump-and-dump trap exacerbated by a six-month share lock-up for early investors.

iShares Trust - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The Russell 2000 ETF is currently trading amidst intense volatility as market participants weigh conflicting geopolitical headlines and institutional hedging activity against the backdrop of an upcoming Federal Reserve decision. Community sentiment is deeply divided, with many traders closely monitoring $250 as a pivotal technical level while debating whether recent price swings are driven by genuine economic data or aggressive institutional manipulation.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is drawing significant attention from investors as it aggressively scales its autonomous drone and defense technology ecosystem through a series of strategic acquisitions, most recently securing World View. Community discourse is heavily focused on the company's raised revenue guidance and its strengthening position as a prime defense contractor, with traders actively debating the impact of these developments ahead of the upcoming earnings conference call.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two Interactive is experiencing heightened volatility as investors weigh strong quarterly earnings and raised guidance against a frustrating, repeated delay of the highly anticipated Grand Theft Auto VI, now pushed to late 2026. The community is sharply divided, with bulls viewing the stock as a long-term value opportunity while vocal critics and skeptics express deep frustration over management's handling of release timelines and potential information leaks.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is currently seeing intense debate among traders regarding its near-term price direction, with some focusing on bullish institutional accumulation and seasonal rate catalysts while others express deep concern over regulatory probes and a recent shelf offering. Community sentiment remains polarized, as participants actively weigh the stock's role as a defensive holding against a backdrop of technical volatility and institutional flow signaling a potential break from its persistent trading range.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure as investors grapple with concerns over Azure growth potential and its heavy capital expenditures, leading to a period of pronounced technical weakness that has the community divided on whether to buy the dip or prepare for further downside. The stock is currently underperforming broader tech indexes, with traders heavily debating the company's long-term AI execution versus the immediate impact of bearish technical trends and negative option flow.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Zen Upgrades Ovid Therapeutics (NASDAQ:OVID) to Hold

Wall Street Zen raised shares of Ovid Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Wedbush Forecasts Strong Price Appreciation for Ovid Therapeutics (NASDAQ:OVID) Stock

Wedbush lifted their target price on Ovid Therapeutics from $5.00 to $7.00 and gave the stock an "outperform" rating in a research note on Friday...

Ovid Therapeutics Q4 Earnings Call Highlights

Ovid Therapeutics (NASDAQ:OVID) outlined new pipeline and financing updates alongside its fourth-quarter and full-year 2025 results, highlighting regulatory clearance in Australia for its KCC2 direct...

Here's Why Ovid Therapeutics Stock Popped Higher Today

Key PointsOV329 may be safer and more potent than existing treatments...

Ovid Therapeutics' New Epilepsy Trial Data Ignites Rally

Ovid Therapeutics shares climb after positive epilepsy data, new trial launch, and $60 million funding boost extending runway into 2028.read more...

Ovid Therapeutics (NASDAQ:OVID) Issues Quarterly Earnings Results, Beats Expectations By $0.16 EPS

Ovid Therapeutics (NASDAQ:OVID - Get Free Report) released its earnings results on Tuesday. The company reported $0.06 earnings per share for the quarter, beating analysts' consensus estimates of...

Ovid Therapeutics (OVID) Q4 Earnings and Revenues Surpass Estimates

Ovid Therapeutics (OVID) delivered earnings and revenue surprises of +158.71% and +195.47%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Niagen Bioscience (NAGE) Tops Q4 Earnings and Revenue Estimates

Niagen Bioscience (NAGE) delivered earnings and revenue surprises of +100.00% and +8.81%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Ovid Therapeutics (OVID) to Release Quarterly Earnings on Tuesday

Ovid Therapeutics (NASDAQ:OVID) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 10. (View Earnings Report at...

Ovid Therapeutics (NASDAQ:OVID) Given Average Recommendation of "Buy" by Analysts

Shares of Ovid Therapeutics (NASDAQ:OVID - Get Free Report) have earned a consensus recommendation of "Buy" from the ten analysts that are presently covering the stock, MarketBeat reports. One...

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.12	--	--	N/A
Q4 '25	-$0.12	$0.06	148.94%	BEAT
Q3 '25	-$0.15	-$0.17	-13.41%	MISSED
Q2 '25	-$0.16	-$0.06	62.70%	BEAT
Q1 '25	-$0.14	-$0.14	-1.81%	MISSED

OVID
Ovid Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest OVID News

OVIDOvid Therapeutics Inc